Aquatic Capital Management LLC Immuno Gen, Inc. Transaction History

Aquatic Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $1.63 Million - $2.3 Million	116,000 New	116,000 $1.84 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $179,830 - $241,080	49,000 New	49,000 $188,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $114,688 - $165,632	25,600 Added 1706.67%	27,100 $130,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $4,725 - $8,640	1,500 New	1,500 $7,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $41,322 - $72,556	-9,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $46,075 - $72,750	9,700 New	9,700 $72,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.